Log in to save to my catalogue

Effect of mycophenolate sodium in scleroderma-related interstitial lung disease

Effect of mycophenolate sodium in scleroderma-related interstitial lung disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_901005681

Effect of mycophenolate sodium in scleroderma-related interstitial lung disease

About this item

Full title

Effect of mycophenolate sodium in scleroderma-related interstitial lung disease

Publisher

London: Springer-Verlag

Journal title

Clinical rheumatology, 2011-11, Vol.30 (11), p.1393-1398

Language

English

Formats

Publication information

Publisher

London: Springer-Verlag

More information

Scope and Contents

Contents

This study aims to determine the effectiveness of mycophenolate sodium (MS) in patients with scleroderma (SSc)-related interstitial lung disease (ILD). In a prospective observational study, we evaluated 14 consecutive SSc-ILD patients who were treated with MS for 12 months. The effect of MS on lung function was examined by using longitudinal data a...

Alternative Titles

Full title

Effect of mycophenolate sodium in scleroderma-related interstitial lung disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_901005681

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_901005681

Other Identifiers

ISSN

0770-3198

E-ISSN

1434-9949

DOI

10.1007/s10067-011-1823-1

How to access this item